Mingxi Lin

1.7k total citations · 1 hit paper
20 papers, 976 citations indexed

About

Mingxi Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mingxi Lin has authored 20 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Mingxi Lin's work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer Diagnosis and Treatment (3 papers). Mingxi Lin is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer Diagnosis and Treatment (3 papers). Mingxi Lin collaborates with scholars based in China, Taiwan and Spain. Mingxi Lin's co-authors include Yizi Jin, Jian Zhang, Cheng Zeng, Xinyu Chen, Teng Zhou, Xin Shen, Xiaomin Ye, Qing Guo, Qianqian Peng and Xiuwei Fan and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Acta Biomaterialia.

In The Last Decade

Mingxi Lin

19 papers receiving 964 citations

Hit Papers

NF-κB in biology and targeted therapy: new insights and t... 2024 2026 2025 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NF-κB in biology and targeted therapy: new insights and translational implications
    2024 799 citations Qing Guo, Yizi Jin et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxi Lin China 7 336 178 140 124 112 20 976
Jun Yu China 19 360 1.1× 108 0.6× 143 1.0× 189 1.5× 53 0.5× 51 982
Yaxian Wu China 21 493 1.5× 279 1.6× 83 0.6× 231 1.9× 293 2.6× 60 1.2k
Sahil Gupta Canada 17 480 1.4× 242 1.4× 95 0.7× 70 0.6× 102 0.9× 35 1.1k
Xinrong Liu China 20 542 1.6× 113 0.6× 118 0.8× 71 0.6× 151 1.3× 79 1.3k
Zhi‐Xiang Xu China 13 541 1.6× 122 0.7× 164 1.2× 130 1.0× 80 0.7× 30 1.0k
Lingyan Wang China 19 437 1.3× 203 1.1× 106 0.8× 95 0.8× 92 0.8× 109 1.1k
Yufeng Lin China 17 651 1.9× 74 0.4× 216 1.5× 126 1.0× 77 0.7× 42 1.2k
Peipei Lu China 18 408 1.2× 108 0.6× 106 0.8× 141 1.1× 95 0.8× 77 1.1k

Countries citing papers authored by Mingxi Lin

Since Specialization
Citations

This map shows the geographic impact of Mingxi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxi Lin more than expected).

Fields of papers citing papers by Mingxi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxi Lin. The network helps show where Mingxi Lin may publish in the future.

Co-authorship network of co-authors of Mingxi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxi Lin. A scholar is included among the top collaborators of Mingxi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxi Lin. Mingxi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaojing, Mingxi Lin, Yizi Jin, et al.. (2025). Overcoming matrix barriers for enhanced immune infiltration using siRNA-coated metal-organic frameworks. Acta Biomaterialia. 196. 410–422. 3 indexed citations
2.
Yu, Siqi, Xiaoting Xu, Jiayi Shen, et al.. (2025). c-di-GMP inhibits rRNA methylation and impairs ribosome assembly in the presence of kanamycin. EMBO Reports. 26(5). 1367–1384. 1 indexed citations
3.
Zhou, Teng, et al.. (2025). Astrocyte involvement in brain metastasis: from biological mechanisms to therapeutic strategies. Cancer and Metastasis Reviews. 44(3). 60–60. 1 indexed citations
4.
Guo, Qing, Yizi Jin, Xinyu Chen, et al.. (2024). NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduction and Targeted Therapy. 9(1). 53–53. 799 indexed citations breakdown →
5.
Jin, Yizi, et al.. (2024). NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges. Life Sciences. 348. 122684–122684. 12 indexed citations
6.
7.
Lin, Mingxi, et al.. (2023). HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort.. Journal of Clinical Oncology. 41(16_suppl). 1021–1021. 1 indexed citations
8.
Liu, Lei, Ruzhi Deng, Wei Zhou, et al.. (2023). [Mechanisms mediating the inhibitory effects of quercetin against phthalates-induced testicular oxidative damage in rats].. PubMed. 43(4). 577–584. 2 indexed citations
9.
Lin, Mingxi, Yizi Jin, Hong Lv, Xichun Hu, & Jian Zhang. (2022). Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases. International Journal of Cancer. 152(7). 1476–1489. 2 indexed citations
10.
Jin, Yizi, Mingxi Lin, Zhiguo Luo, Xichun Hu, & Jian Zhang. (2021). Development and validation of a nomogram for predicting overall survival of patients with cancer of unknown primary: a real-world data analysis. Annals of Translational Medicine. 9(3). 198–198. 4 indexed citations
11.
Lin, Mingxi, Yizi Jin, Ziyi Yang, Xichun Hu, & Jian Zhang. (2021). Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer. Therapeutic Advances in Medical Oncology. 13. 4277434913–4277434913. 3 indexed citations
12.
13.
Lin, Ying, Mingxi Lin, Jian Zhang, et al.. (2020). Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis. Cancer Research and Treatment. 52(4). 1059–1066. 34 indexed citations
14.
15.
Zhang, Jinfeng, Mingxi Lin, Yizi Jin, et al.. (2020). Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia. Breast Cancer Research and Treatment. 182(3). 719–726. 6 indexed citations
16.
17.
Lin, Mingxi, Qianqian Peng, Wei Hou, Xiuwei Fan, & Jie Liu. (2018). 1.3 μm Q-switched solid-state laser based on few-layer ReS2 saturable absorber. Optics & Laser Technology. 109. 90–93. 66 indexed citations
18.
Shao, Chengchen, Mingxi Lin, Zhihan Zhou, et al.. (2016). Mutation analysis of 19 autosomal short tandem repeats in Chinese Han population from Shanghai. International Journal of Legal Medicine. 130(6). 1439–1444. 14 indexed citations
19.
Lin, Mingxi. (2014). Discussion on diabetes mellitus based on ‘spirit, physique, appetite, sleeping, urine and stool'. 1 indexed citations
20.
Hu, Jifan, et al.. (1989). Formation of magnetic phases in Y-Zr-Fe compounds. physica status solidi (a). 113(1). K127–K129. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Yu Breakdown of academic impact, for papers by Yaxian Wu Breakdown of academic impact, for papers by Sahil Gupta Breakdown of academic impact, for papers by Xinrong Liu Breakdown of academic impact, for papers by Zhi‐Xiang Xu Breakdown of academic impact, for papers by Lingyan Wang Breakdown of academic impact, for papers by Yufeng Lin Breakdown of academic impact, for papers by Peipei Lu
Rankless by CCL
2026